Inspira Technologies OXY B.H.N. (QTEX) Stock Price, News & Analysis

Company Overview

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Key Stats

• Today's Range: $2.08 to $3.70
• 50-Day Range: N/A
• 52-Week Range: $0.28 to $3.70
• Volume: 107.47 million shs
• Average Volume: 60.96 million shs
• Market Capitalization: $110.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Inspira Technologies OXY B.H.N. Stock Analysis - MarketRank™

Inspira Technologies OXY B.H.N. scored higher than 1% of companies evaluated by MarketBeat, and ranked 83rd out of 84 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Inspira Technologies OXY B.H.N. has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Inspira Technologies OXY B.H.N. has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Inspira Technologies OXY B.H.N. has a P/B Ratio of 51.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for QTEX.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Inspira Technologies OXY B.H.N. does not currently pay a dividend.

Dividend Growth

Inspira Technologies OXY B.H.N. does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 4 news articles for Inspira Technologies OXY B.H.N. this week, compared to 5 articles on an average week.

Search Interest

109 people have searched for QTEX on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added Inspira Technologies OXY B.H.N. to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Inspira Technologies OXY B.H.N. insiders have not sold or bought any company stock.

Percentage Held by Insiders

29.40% of the stock of Inspira Technologies OXY B.H.N. is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

12.72% of the stock of Inspira Technologies OXY B.H.N. is held by institutions.

Company Calendar

• Today: 5/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:QTEX
• CIK: 1837493
• Web: N/A
• Phone: 972-9-9664488
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 1.56
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $290 thousand
• Price / Sales: 380.57
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.06 per share
• Price / Book: 51.17

Miscellaneous

• Outstanding Shares: 35,950,000
• Free Float: 25,380,000
• Market Cap: $110.37 million
• Optionable: N/A
• Beta: 2.16